Differential immunophenotypic analysis of dendritic cell tumours

Journal of Clinical Pathology

Volumn 63, Issue 6, 2010, Pages 497-503

  Orii, Tomohiko ^a   Takeda, Hiroaki ^a   Kawata, Sumio ^a   Maeda, Kunihiko ^a   Yamakawa, Mitsunori ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CYCLIN A; CYCLIN B; FASCIN; HISTONE H3; KI 67 ANTIGEN; LANGERIN; PROTEIN P53; PROTEIN S 100; T6 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CELL CYCLE; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL SARCOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLICULAR DENDRITIC CELL; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LANGERHANS CELL; LANGERHANS CELL SARCOMA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CELL CYCLE PROTEINS; CHILD; DENDRITIC CELL SARCOMA, INTERDIGITATING; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HISTIOCYTOSIS, LANGERHANS-CELL; HISTONES; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LANGERHANS CELL SARCOMA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77953693786     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.067819     Document Type: Article

References (26)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO classification of tumours, tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: IARC, 2008.
2. Gasent Blesa JM, Alberola Candel V, Solano Vercet C, et al. Langerhans cell histiocytosis. Clin Transl Oncol 2008;10:688-96.
3. Bohn OL, Ruiz-Argüelles G, Navarro L, et al. Cutaneous langerhans cell sarcoma: a case report and review of the literature. Int J Hematol 2007;85:116-20.
4. Zhao G, Luo M, Wu ZY, et al. Clinical and pathological features of Langerhans cell sarcoma: a case report of langerhans cell sarcoma involving gallbladder and peritoneal lymph nodes. Int J Surg Pathol 2008. (Epub ahead of print).
5. Maeda K, Takahashi T, Saitoh C, et al. Interdigitating cell sarcoma - a report of an autopsy case and literature review. J Clin Exp Hematop 2005;45:37-44.
6. Zhou ZY, Sun RC, Yang SD, et al. Interdigitating dendritic cell tumor of the lymph node in the right submaxillary region: a case report and review of the literature. Int J Surg Pathol 2009. (Epub ahead of print).
7. Fonseca R, Yamakawa M, Nakamura S, et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma; a review. Am J Hematol 1998;59:161-7.
8. Kairouz S, Hashash J, Kabbara W, et al. Dendritic cell neoplasms: an overview. Am J Hematol 2007;82:924-8.
9. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International lymphoma study group based on 61 cases. Histopathology 2002;41:1-29.
10. Bank MI, Rengtved P, Carstensen H, et al. p53 expression in biopsies from children with langerhans cell histiocytosis. J Pediatr Hematol Oncol 2002;24:733-6.
11. Petersen BL, Rengtved P, Bank MI, et al. High expression of markers of apoptosis in langerhans cell histiocytosis. Histopathology 2003;42:186-93.
12. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annu Rev Immunol 2009. (Epub ahead of print).
13. Buckner JH, Ziegler SF. Functional analysis of FOXP3. Ann N Y Acad Sci 2008;1143:151-69.
14. + regulatory T cells as biomarkers in human malignancies. Expert Opin Biol Ther 2008;8:1897-920.
15. Yamakawa M, Matsuda M, Imai Y, et al. Lymph node interdigitating cell sarcoma: a case report. Am J Clin Pathol 1992;97:139-44.
16. Gaertner EM, Tsokos M, Derringer GA, et al. Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 2001;115:589-97.
17. Brabencova E, Tazi A, Lorenzato M, et al. Langerhans cells in langerhans cell granulomatosis are not actively proliferating cells. Am J Pathol 1998;152:1143-9.
18. Handa K, Yamakawa M, Takeda H, et al. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as indicator of poor prognosis. Int J Cancer 1999;84:225-33.
19. Amir G, Weintraub M. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in langerhans cell histiocytosis. Pediatr Blood Cancer 2008;50:304-7.
20. Magnaghi-Jaulin L, Ait-Si-Ali S, Harel-Bellan A. Histone acetylation in signal transduction by growth regulatory signals. Semin Cell Dev Biol 1999;10:197-203.
21. Ishihama K, Yamakawa M, Semba S, et al. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J Clin Pathol 2007;60:1205-10.
22. Sutmuller RP, Morgan ME, Netea MG, et al. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 2006;27:387-92.
23. + regulatory T cells. J Immunol 2004;173:4433-42.
24. + regulatory T cells bear functional skin-homing receptors. J Immunol 2006;177:4488-94.
25. Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001;31:812-22.
26. Fleming MD, Pinkus JL, Fournier MV, et al. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic langerhans cells in langerhans cell histiocytosis. Blood 2003;101:2473-5.